SUN Jiang-jie, SU Wei-xin, ZHOU Yan-ning, ZHANG Yan, HUANG He, SHI Rui. Current Status of Research on Pathological Characteristics Associated With Postoperative Recurrence and Development of Risk Prediction Models in Early-Stage Non-Small Cell Lung CancerJ. Journal of Evidence-Based Medicine, 2025, 25(2): 124-128. DOI: 10.12019/j.issn.1671-5144.202502026
Citation:
SUN Jiang-jie, SU Wei-xin, ZHOU Yan-ning, ZHANG Yan, HUANG He, SHI Rui. Current Status of Research on Pathological Characteristics Associated With Postoperative Recurrence and Development of Risk Prediction Models in Early-Stage Non-Small Cell Lung CancerJ. Journal of Evidence-Based Medicine, 2025, 25(2): 124-128. DOI: 10.12019/j.issn.1671-5144.202502026
SUN Jiang-jie, SU Wei-xin, ZHOU Yan-ning, ZHANG Yan, HUANG He, SHI Rui. Current Status of Research on Pathological Characteristics Associated With Postoperative Recurrence and Development of Risk Prediction Models in Early-Stage Non-Small Cell Lung CancerJ. Journal of Evidence-Based Medicine, 2025, 25(2): 124-128. DOI: 10.12019/j.issn.1671-5144.202502026
Citation:
SUN Jiang-jie, SU Wei-xin, ZHOU Yan-ning, ZHANG Yan, HUANG He, SHI Rui. Current Status of Research on Pathological Characteristics Associated With Postoperative Recurrence and Development of Risk Prediction Models in Early-Stage Non-Small Cell Lung CancerJ. Journal of Evidence-Based Medicine, 2025, 25(2): 124-128. DOI: 10.12019/j.issn.1671-5144.202502026
Current Status of Research on Pathological Characteristics Associated With Postoperative Recurrence and Development of Risk Prediction Models in Early-Stage Non-Small Cell Lung Cancer
No content published by the Journal of Evidence-Based Medicine may be reproduced or abridged without authorization. Please do not use or copy the layout and design of the journal without permission.
All articles published represent the opinions of the authors, and do not reflect the official policy of the Journal of Evidence-Based Medicine’ Sponsors or the Editorial Board, unless this is clearly specified.
Postoperative recurrence and metastasis represent critical causes of treatment failure in early-stage non-small cell lung cancer (NSCLC), with the identification of high-risk factors for postoperative relapse remaining a central focus in clinical research. Pathological characteristics have been extensively investigated, with numerous studies confirming that high-grade histopathological subtypes, visceral pleural invasion, vascular invasion, and spread through air spaces constitute well-established high-risk factors for tumor recurrence and metastasis. In the era of rapidly advancing artificial intelligence, the development of risk prediction models facilitates precise identification of postoperative high-risk patients, thereby providing valuable guidance for adjuvant therapy strategies and follow-up management. This review systematically examines the high-risk pathological features associated with postoperative recurrence in early-stage lung cancer and evaluates current advancements in constructing risk prediction models based on pathological characteristics.